Obesity Trial, Recruiting NCT04755062 Sponsor: Northern Arizona University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT04755062
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as Native American and work as an employee at Twin Arrows Casino
  • People between 21 and 65 years of age
  • People with a self-reported Body Mass Index (BMI) — a measure of body weight relative to height — above 24 kg/m² (confirm with trial site for how this is calculated)
  • People who are not currently taking part in any weight-loss program
  • People who are not currently taking medications that could increase medical risk (such as insulin) or that cause weight loss as a main side effect
  • People who have worked at Navajo Gaming Enterprise for at least one year before the study begins and plan to continue working there for the full length of the study

Who may not be able to join:

  • People who have had weight-loss surgery, including gastric bypass, adjustable gastric band, gastric sleeve, or duodenal switch procedures
  • People who are currently pregnant or planning to become pregnant within the next year
  • People who rely on insulin to manage their health
  • People who are unable to attend weekly group coaching sessions in person

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nanette Lopez, PhD, MS/MS, Northern Arizona University

Phone: 928-523-7913

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Northern Arizona University
Registry
ClinicalTrials.gov
Start date
18 January 2023
Est. completion
1 January 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from baseline Hemoglobin A1c (HgA1c) at week 13 and week 26

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov